Named one of Michigan 50 Companies to Watch

Celsee Diagnostics (formerly operating as DeNovo Sciences) provides next-gen microfluidic systems for automated label-free single-cell circulating tumor cell (CTC) detection and analysis.

Celsee Diagnostics offers a fully automated circulating tumor cell (CTC) detection system that has the ability to analyze biomarkers at a single-cell level. Downstream molecular and genetic analysis on single cells is a crucial component in the development of personalized therapy. This laboratory-based platform enables the user to process samples at the site of collection, substantially reducing time to result, and the label-free isolation method ensures unlimited assay expansion.